AICF's 2020-21 Fellow:
Luca Cappelli, MD
Enhanced NK-cell adoptive transfer: a bridge to complete remission in hematologic malignancies
"I am an MD with a background on chronic lymphocytic leukemia and acute myeloid leukemia. I am currently spending a research period at Weill Cornell Medicine as part of my PhD focusing on the development of patient-derived tumor xenograft models of hematopoietic cancer. My AICF project proposes a strategy to engineer NK cells to enhance their survival, proliferation and killing abilities. This could provide an alternative to CAR-T cells in a number of clinical settings, including induction and consolidation/minimal residual disease eradication."